ES8105709A1 - Un procedimiento para la preparacion de derivados de azeti din-2-ona. - Google Patents

Un procedimiento para la preparacion de derivados de azeti din-2-ona.

Info

Publication number
ES8105709A1
ES8105709A1 ES493599A ES493599A ES8105709A1 ES 8105709 A1 ES8105709 A1 ES 8105709A1 ES 493599 A ES493599 A ES 493599A ES 493599 A ES493599 A ES 493599A ES 8105709 A1 ES8105709 A1 ES 8105709A1
Authority
ES
Spain
Prior art keywords
derivatives
procedure
elevated
formula
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES493599A
Other languages
English (en)
Spanish (es)
Other versions
ES493599A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES493599A0 publication Critical patent/ES493599A0/es
Publication of ES8105709A1 publication Critical patent/ES8105709A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/04—Preparation by forming the ring or condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES493599A 1979-07-23 1980-07-22 Un procedimiento para la preparacion de derivados de azeti din-2-ona. Expired ES8105709A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5984479A 1979-07-23 1979-07-23

Publications (2)

Publication Number Publication Date
ES493599A0 ES493599A0 (es) 1981-06-16
ES8105709A1 true ES8105709A1 (es) 1981-06-16

Family

ID=22025641

Family Applications (1)

Application Number Title Priority Date Filing Date
ES493599A Expired ES8105709A1 (es) 1979-07-23 1980-07-22 Un procedimiento para la preparacion de derivados de azeti din-2-ona.

Country Status (9)

Country Link
EP (1) EP0026816B1 (enExample)
JP (3) JPS5620571A (enExample)
AT (1) ATE7690T1 (enExample)
DE (1) DE3068029D1 (enExample)
DK (1) DK314380A (enExample)
ES (1) ES8105709A1 (enExample)
GR (1) GR69337B (enExample)
IE (1) IE50070B1 (enExample)
PT (1) PT71553B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3276316D1 (en) * 1981-08-27 1987-06-19 Fujisawa Pharmaceutical Co Carbapenam compound and processes for the preparation thereof
HU184495B (en) * 1981-12-30 1984-08-28 Richter Gedeon Vegyeszet Process for preparing new azetidinone-acetic acids
HU184496B (en) * 1981-12-30 1984-08-28 Richter Gedeon Vegyeszet Process for producing new azetidinon-acetic acid derivatives
HU185081B (en) * 1981-12-30 1984-11-28 Richter Gedeon Vegyeszet Process for preparing azetidinone-acetic acid derivatives
JPS58167566A (ja) * 1982-03-27 1983-10-03 Kanegafuchi Chem Ind Co Ltd （４ｒ）−（２−ヒドロキシエチル）−２−アゼチジノン及びその誘導体の製法
HU190404B (en) * 1982-07-30 1986-09-29 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for preparing amino-lactone-carboxylic acid
HU187424B (en) * 1982-11-05 1986-01-28 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for preparing new azetidinyl-acetic acids
CA1220215A (en) * 1983-03-07 1987-04-07 Yasutsugu Ueda Carbapenem intermediates
HU188913B (en) * 1983-06-23 1986-05-28 Richter Gedeon Vegyeszeti Gyar,Rt,Hu Process for producing new azetidinyl-acetic acid esters
NZ214691A (en) * 1984-12-27 1988-08-30 Sumitomo Pharma The preparation of carbapenem derivatives and beta-lactam intermediates
EP0937725A3 (en) 1992-04-28 2004-12-01 Tanabe Seiyaku Co., Ltd. Method for removing the protecting group for hydroxy group
US8157837B2 (en) 2006-03-13 2012-04-17 Pneumrx, Inc. Minimally invasive lung volume reduction device and method
US8888800B2 (en) 2006-03-13 2014-11-18 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US9402633B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4174316A (en) * 1978-08-14 1979-11-13 Merck & Co., Inc. 4-Iodomethylazetidin-2-one

Also Published As

Publication number Publication date
PT71553B (en) 1981-12-14
EP0026816A1 (en) 1981-04-15
DK314380A (da) 1981-01-24
JPH0223558B2 (enExample) 1990-05-24
JPS6479147A (en) 1989-03-24
ES493599A0 (es) 1981-06-16
IE50070B1 (en) 1986-02-05
ATE7690T1 (de) 1984-06-15
JPH02160763A (ja) 1990-06-20
EP0026816B1 (en) 1984-05-30
DE3068029D1 (en) 1984-07-05
JPH047740B2 (enExample) 1992-02-12
PT71553A (en) 1980-08-01
IE801503L (en) 1981-01-23
JPH0422908B2 (enExample) 1992-04-20
JPS5620571A (en) 1981-02-26
GR69337B (enExample) 1982-05-17

Similar Documents

Publication Publication Date Title
FR2360587A1 (fr) Nouveaux derives d'amino-alcoyl-furannes utiles comme medicaments
HK94986A (en) Therapeutic agents
KR830007662A (ko) 5,6,7,7a-테트라하이드로-4H-티에노 [3,2-c]-피리딘-2-온 유도체의 제조방법
IE42628L (en) 1,3,4-oxadiazoline derivatives
ES401710A1 (es) Procedimiento para la preparacion de nuevos compuestos bi- ciclicos nitrogenados.
FR2452483A1 (fr) Derives d'alcenylphenylmaleimides, leurs dimeres lineaires et leur procede de preparation
FR2514355B1 (enExample)
IE780778L (en) 3-pyridazinones.
FR2359111A1 (fr) Nouveaux derives d'acides phenoxyphenoxy-alcanecarboxyliques utiles comme herbicides
FR2377382A1 (fr) Nouveaux phenylazacycloalcanes utiles comme medicaments
LTIP1676A (en) Novel 16,17-acetal-substituted androstan-17beta-carboxylic acid esters, process for preparing thereof, pharmaceutical preparations
JPS5515443A (en) Antibacterial agent
FR2355823A1 (fr) Derives isoindoliques
SE8004621L (sv) Bensimidazolderivat
GB2004885A (en) Indolopyrones
ES357216A2 (es) Procedimiento para la preparacion de derivados de isoindol
ES445960A1 (es) Procedimiento de preparacion de derivados fosforados.
FR2374319A1 (fr) Furanne- et thiophenecarbaldehydes substitues et furylalkylcetones substituees et thienylalkylcetones substituees, utiles notamment comme agents anti-rhinovirus, et leur procede de preparation
AU5006679A (en) Pyrano (3,2-c)quinoline derivatives
IE782218L (en) TRIAZOLO (4,5-b) QUINOLINES
AU557502B2 (en) Dithiino(1,4)(2,3-c)pyrrole derivatives
HUT50833A (en) Process for producing indolo/3,2-1-de/ /1,4/-oxazino/2,3,4-ij/ /1,5/-naphthyridine derivatives
JPS525730A (en) Process for preparation of 1,3,5-tri-substituted derivatives
JPS51128938A (en) Thereof and their uses carbonates and, process for preparing
JPS5325543A (en) Triafulvene-iron complexes

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203